Last Traded Price : ₹5.95
About
API Holdings is India's largest digital healthcare platform (based on GMV of products and services sold for the year ended March 31, 2021) which operates an integrated, end-to-end business solving the healthcare needs of consumers through technology and fulfilment capabilities. Our custom-built technology platform aims to provide each stakeholder in the healthcare value-chain benefits of an interconnected network. We work closely with and build services for consumers, pharmaceutical companies, wholesalers, pharmacies, hospitals, doctors and clinics, and diagnostic labs. Our growing nationwide presence, the connected ecosystem approach, and multiple synergistic offerings have enabled us to build relationships with various stakeholders of the healthcare value chain.
Read moreFundamental
Company Name :
API Holdings Limited
API Holdings Limited
Scrip Name :
PharmEasy
PharmEasy
ISIN No. :
INE0DJ201029
INE0DJ201029
No. of Outstanding Shares :
17,032,495,304
17,032,495,304
PAN No. :
AASCA1201E
AASCA1201E
Face Value :
₹1.00
₹1.00
EPS :
₹-0.92
₹-0.92
PE ratio :
-6.45
-6.45
P/S Ratio :
1.69
1.69
Market Capitalization :
₹10,134.33 Crore
₹10,134.33 Crore
Book value :
₹1.76
₹1.76
P/BV :
3.37
3.37
52 Week High :
₹ 10.25 (24/01/25)
₹ 10.25 (24/01/25)
52 Week Low :
₹ 6.00 (05/10/25)
₹ 6.00 (05/10/25)
Lifetime High :
₹ 135.00 (20/11/21)
₹ 135.00 (20/11/21)
Lifetime Low :
₹ 6.00 (05/10/25)
₹ 6.00 (05/10/25)
DRHP Filed ?
Yes
Yes
Available on :
NSDL and CDSL
NSDL and CDSL
ROFR Require :
No
No
Sector :
eCommerce
eCommerce
CIN :
U60100MH2019PLC323444
U60100MH2019PLC323444
Registration Date :
31/03/2019
31/03/2019
Balance Sheet (RS in Millions)
| Particulars | 2025 | 2024 |
|---|---|---|
| Non-current assets | ||
| Property, plant and equipment | 2,687.48 | 2,862.44 |
| Right-of-use assets | 1,314.26 | 1,385.84 |
| Capital work-in-progress | 141.62 | 27.56 |
| Goodwill | 35,133.38 | 36,911.84 |
| Other intangible assets | 3,930.57 | 4,474.21 |
| Intangible assets under development | - | 9.48 |
| Investments accounted for using the equity method | 241.67 | 1,748.03 |
| Investments | 177.62 | 174.62 |
| Other financial assets | 261.2 | 249.95 |
| Deferred tax assets (net) | 144.13 | 426.98 |
| Income tax assets (net) | 568.92 | 758.44 |
| Other non-current assets | 38.71 | 104.68 |
| Current assets | ||
| Inventories | 5,538.91 | 5,555.60 |
| Investments | 1,373.64 | 1,367.55 |
| Trade receivables | 6,695.08 | 7,062.10 |
| Cash and cash equivalents | 1,189.91 | 3,279.89 |
| Other bank balances | 6,207.66 | 12,825.02 |
| Loans | 0.43 | 695.58 |
| Other financial assets | 916.15 | 862.62 |
| Other current assets | 3,196.44 | 3,071.28 |
| Assets classified as held for sale | 8.06 | 42.89 |
| Total assets | 69,765.84 | 83,896.60 |
| Equity | ||
| Equity Share capital | 6,516.67 | 6,240.44 |
| Instruments entirely in the nature of equity | 433 | 256.53 |
| Other equity | 23,089.18 | 15,647.45 |
| Equity component of compound financial instruments | 30,038.85 | 22,144.42 |
| Non-controlling interests | 2,683.96 | 3,738.68 |
| Non-current liabilities | ||
| Borrowings | 16,840.92 | 20,243.92 |
| Lease liabilities | 913.75 | 900.39 |
| Provisions | 131.63 | 111.66 |
| Deferred tax liabilities (net) | 1,344.57 | 1,732.70 |
| Contract liabilities | 0.01 | - |
| Current liabilities | ||
| Borrowings | 3,495.76 | 20,739.65 |
| Lease liabilities | 267.2 | 310.25 |
| Trade payables | ||
| Total outstanding dues of micro and small enterprises | 252.97 | 330.57 |
| Total outstanding dues of other than micro/small entrp. | 4,014.13 | 3,798.50 |
| Other current liabilities | 7,577.52 | 7,752.28 |
| Other Contract liabilities | 1,643.72 | 1,618.82 |
| Contract liabilities | 228.94 | 130.79 |
| Provisions | 291.3 | 302.91 |
| Current tax liabilities (net) | 40.61 | 41.06 |
| Total equity and liabilities | 69,765.84 | 83,896.60 |
Profit & Loss Statement (RS in Millions)
| Particulars | 2025 | 2024 |
|---|---|---|
| Income | ||
| Revenue from operations | 58,721.64 | 56,642.86 |
| Other income | 1,078.65 | 946.55 |
| Total Income | 59800.29 | 57589.41 |
| Expenses | ||
| Cost of Material Consumed | 1,886.02 | 1,645.09 |
| Purchase of stock-in-trade | 47,295.83 | 45,728.06 |
| Changes in inventories of stock-in-trade | -39.76 | 1,430.14 |
| Employee benefits expense | 9,083.99 | 6,993.63 |
| Finance costs | 5,061.07 | 7,279.16 |
| Depreciation and amortization expense | 1,689.78 | 2,159.52 |
| Expected credit loss on financial assets | 1,001.25 | 1,692.64 |
| Other expenses | 6,107.40 | 5,619.76 |
| Total Expenses | 72085.58 | 72548 |
| Loss before exceptional items, share of net profit/ (loss) of investments accounted for using the equity method and tax | ||
| Share of profit/(loss) of Investments accounted for using the equity method | 81.55 | 8.75 |
| Loss before exceptional items and tax | -12203.74 | -14949.84 |
| Exceptional items | ||
| Impairment of goodwill | -1,750.00 | -5,825.00 |
| Impairment of investments in associates | -198.13 | -5,825.00 |
| Early redemption charges for NCDs | 0 | -5,825.00 |
| Others | -1,016.98 | -5,825.00 |
| Loss before tax | -15168.85 | -5,825.00 |
| Tax Expense | ||
| Current tax | 651.07 | 379.21 |
| Deferred tax charge/(credit) | -102.21 | -270.03 |
| Tax expense pertaining to prior periods | 6.18 | 6.23 |
| Total tax expense | 555.04 | 115.41 |
| Loss after tax | -15723.89 | -25219.72 |
| Other comprehensive income | ||
| Remeasurements of post-employment defined benefit plans | -3.18 | 24.64 |
| Income tax relating to above items | 3.08 | -1.22 |
| Other comprehensive income, net of tax | -0.1 | 23.42 |
| Total comprehensive loss | (15,723.99) | | -25311.71 |
| Profit/(loss) for the period attributable to: | ||
| Owners of API Holdings Limited | -15,931.93 | -25,499.51 |
| Non controlling interest | 208.04 | 164.38 |
| Other comprehensive income /(loss) for the period attributable: | ||
| Owners of API Holdings Limited | 2.12 | 21.69 |
| Non-controlling interest | -2.22 | 1.73 |
| Total comprehensive income /(loss) for the period attributable: | ||
| Owners of API Holdings Limited | -15929.81 | -25477.82 |
| Non-controlling interest | 205.82 | 166.11 |
| Loss per share attributable to owners of the group | ||
| Basic EPS | -1.05 | -3.02 |
| Diluted EPS | -1.05 | -3.02 |
Cash Flow Statement (RS in Millions)
| Particulars | 2025 | 2024 |
|---|---|---|
| Cash flow from operating activities | ||
| Loss before tax | -15,168.85 | -25,219.72 |
| Adjustments for | ||
| Depreciation and Amortization Expenses | 1,689.78 | 2,159.52 |
| Finance Costs | 5,061.07 | 7,279.16 |
| Early redemption charges for NCD's | - | 3,424.94 |
| Net loss on disposal of property, plant, and equipment | 22.9 | 109.66 |
| Gain on fair valuation of financial instruments (net) | -35.68 | -96.25 |
| Gain on sale of financial assets at FVPL (net) | -77.16 | -0.14 |
| Impairment of goodwill | 1,750.00 | 5,825.00 |
| Impairment of investments (equity method) | 198.13 | 334.25 |
| Impairment of PPE & Intangibles | 8.78 | 426.99 |
| Impairment of loans in associates | 572.07 | - |
| Loss on sale of investments in subs/associates | 444.91 | - |
| Change in fair value of assets held for sale | -40.03 | 60 |
| Gain on termination/modification of leases | -29.69 | -45.85 |
| Liabilities no longer required written back | -25.23 | -34.81 |
| Employee share-based payment expense | 4,822.46 | 2,218.52 |
| Unwinding of interest on security deposits | -16.07 | -15.54 |
| Impairment allowance for doubtful advances & govt balances | 406.08 | 464.66 |
| Expected credit loss on financial assets | 1,001.25 | 1,692.64 |
| Share of (profit)/loss of investments (equity method) | -81.55 | -8.75 |
| Amortization of financial guarantee liability | -4.36 | -21.43 |
| Interest income | -862.43 | -689.8 |
| Operating (loss) before working capital changes | -363.62 | -2136.85 |
| Changes in working capital: | ||
| (Increase)/decrease in other current/non-current fin. assets | -588.81 | 322.81 |
| (Increase)/decrease in other curr/non-current assets | -11.28 | -318.29 |
| (Increase)/decrease in trade receivables | -560.2 | 295.6 |
| (Increase)/decrease in inventories | 16.69 | 1,326.00 |
| Increase/(decrease) in other curr/non-current fin. liabilities | -469.58 | 204.77 |
| Increase/(decrease) in other curr/non-current liabilities | 24.9 | 127.51 |
| Increase/(decrease) in trade payables | 81.49 | -5.04 |
| Increase/(decrease) in provisions | 8.81 | -59.81 |
| Increase/(decrease) in contract liabilities | 98.16 | -11.08 |
| Cash used in operations | -1,764.07 | -254.28 |
| Income taxes paid (net of refund) | -471.25 | -357.08 |
| Net cash flow used in operating activities | -2,235.32 | -611.36 |
| Cash flow from investing activities | ||
| Purchase of property, plant, and equipment, intangibles | -806.37 | -723.14 |
| Proceeds from sale of PPE and intangibles | 218.01 | 101.57 |
| Proceeds from sale of investments (equity method) | 1,018.44 | - |
| Proceeds from sale of investments in subsidiary | 0.87 | - |
| Payments for purchase of investments (net) | -330.54 | -1,081.05 |
| Payments for purchase of mutual funds | - | -1,500.00 |
| Proceeds from sale of mutual funds | 81.99 | 1,422.87 |
| Loans and advances given | - | -54.3 |
| Proceeds from repayment of loans and advances given | 241.33 | 530 |
| Payment for placement of fixed deposits with banks | - | -17,007.83 |
| Proceeds from withdrawal of fixed deposits with banks | 6,617.36 | 5,221.50 |
| Interest received | 832.29 | 543.37 |
| Consideration paid for business acquisitions | -123.57 | -62.49 |
| Net cash flow used in investing activities | 7,749.61 | -12,609.50 |
| Cash flow from financing activities | ||
| Payment of share issue costs | - | -53.59 |
| Proceed from issue of CCPS | 18,088.06 | 20,000.80 |
| Dividends paid to non-controlling interests | -281.71 | -295.08 |
| Proceeds from /Repayments of short-term borrowings (net) | -4,120.76 | -2,102.32 |
| Repayment of long-term borrowings | -18,451.53 | -494.31 |
| Proceeds from long-term borrowings | 700 | 286.29 |
| Interest paid | -3,080.54 | -2,288.57 |
| Proceeds towards capital contribution by NCI | 3.24 | 12.24 |
| Principal portion of lease payments | -301.21 | -338.54 |
| Interest portion of lease liabilities | -154.66 | -158.59 |
| Net cash flow from financing activities | -7,599.11 | 14,568.33 |
| Net cash flows during the year | -2,084.82 | 1,347.47 |
| Cash and cash equivalents (opening balance) | 3,274.45 | 1,926.98 |
| Cash and cash equivalents (closing balance) | 1,189.63 | 3,274.45 |
We’re sorry, but Financial Ratio data for this company is not available right now.
How Its Work
Our team will contact you via Email or Phone
Contact our team to get the best prices for the shares you wish to buy or sell.
Secure Transaction Process
After deal confirmation and KYC, the seller transfers shares to our Demat account, while the buyer safely sends payment to our bank account.
Deal Completion
The final stage of the transaction where legal documents are signed, payments are settled, and ownership is officially transferred.